Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2000
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1050305A1 A composition for the treatment of stomach ulcers, duodenal ulcers and ulcers of the digestive system
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049717A2 Antibodies against human il-12
11/08/2000EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049691A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
11/08/2000EP1049679A2 Sulphonamide derivatives for treatment of cns disorders
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP1049472A1 Antagonists of gonadotropin releasing hormone
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000CN1272877A Feed product
11/08/2000CN1272846A 8-substituted-9H-1,3-dioxolo/4,5-h/2,3/benzodiazepine derivatives, as Ampa/kainate receptor inhibitors
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272791A Pharmaceutical preparation comprising lactobacillus casei phamnosus
11/08/2000CN1272789A Pharmaceutical compositions for oral administration of molecular iodine
11/08/2000CN1272373A Navel-mounting adhesive plaster for curing cirrhosis of liver and intractable ascites
11/08/2000CN1272367A Preparation of body-nourishing honey pill food
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/08/2000CN1058175C Traditional Chinese medicine for treating constipation
11/08/2000CN1058173C Traditional Chinese medicine preparation for curing hepatic disease and gallstones
11/08/2000CN1058168C Medicine for curing stomach disease and preparing method thereof
11/08/2000CN1058165C Chinese drugs preparation for curing hepatitis B and its preparing method
11/08/2000CN1058163C Medicine for curing hepatitis B
11/08/2000CN1058157C Stomach medicine composition
11/07/2000US6143785 Inflammatory bowel disease with alkanoyl carnitine in solution
11/07/2000US6143783 Amino acids
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143761 2,3-dihydrofuro [3,2-β]pyridin, preparation and application thereof in therapy
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143743 Treatment of nervous system disorders
11/07/2000US6143306 Methods for treating pancreatic disorders
11/07/2000US6143302 Headache and colic relief composition with asafetida and method of use thereof
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065031A1 Human cell line showing stable expression of cytochromes p450
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064900A1 Pyrazolobenzodiazepines as cdk2 inhibitors
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064538A1 Products and methods for brachytherapy
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064478A1 Preventives/remedies for liver diseases
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000WO2000064453A1 Intestinal fermentation sulfide deodorizers
11/02/2000WO2000064444A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064430A1 Apoptosis inhibitors
11/02/2000WO2000064414A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000WO2000064273A1 Complete feed for fish larvae and method for preparing same
11/02/2000WO2000046235B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
11/02/2000WO2000042987A3 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000035408A3 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1048297A2 Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047785A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure
11/02/2000EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
11/02/2000EP1047688A1 Thiophene nitrone compounds
11/02/2000EP1047683A1 Thioether furan nitrone compounds
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047426A1 Use of methylnaltrexone and related compounds
11/02/2000EP1047395A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
11/02/2000EP0812207B1 Morphogen-induced dentine regeneration
11/02/2000DE19918210A1 Gelled milk composition useful for treating intestinal inflammation containing colostral protective factors, obtained by treating colostrum or lactoserum with thickening and/or gelling agent,
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000CA2370590A1 Agent for suppressing the odors of sulfides formed through fermentation in the large intestine
11/02/2000CA2370581A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000CA2370365A1 Human cell line showing stable expression of cytochromes p450
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369951A1 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000CA2367980A1 Complete feed for fish larvae and method for preparing same
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition